Early Experience Treating Vestibular Migraine With Small Molecule CGRP Antagonists.

Key Points

• To evaluate the effectiveness of small molecule CGRP antagonists in treating vestibular migraine.
• Overview of gepant use for vestibular migraine management
• Assessment of patient tolerance to gepants
• Gepants are well-tolerated by patients
• Gepants show promise as effective agents for vestibular migraine treatment